Deals
Glenview Scores Win over Carl Icahn as ISS Supports Cigna’s Deal Plan
- ISS joins Glenview Capital in supporting $54 billion takeover
- Amazon and regulatory threats still loom for Express, ISS says
Carl Icahn.
Photographer: Victor J. Blue/This article is for subscribers only.
Cigna Corp.’s proposed $54 billion acquisition of Express Scripts Holding Co. got a boost Friday after a prominent shareholder advisory firm said the deal is “financially compelling.”
The recommendation is at odds with billionaire investor Carl Icahn’s efforts to drum up investor opposition to the takeover of the pharmacy benefit manager ahead of an Aug. 24 shareholder vote. He’s called the potential merger “a travesty” that could go down as one of the worst in history.